Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
experienced hemorrhage, subcraneal bleeding that almost killed me; almost killed me; now the discovered low blood platelets count; This is a solicited report received from a Consumer or other non HCP, Program ID: . A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SUBARACHNOID HAEMORRHAGE (medically significant), outcome "unknown", described as "experienced hemorrhage, subcraneal bleeding that almost killed me"; NEAR DEATH EXPERIENCE (medically significant), outcome "unknown", described as "almost killed me"; PLATELET COUNT DECREASED (non-serious), outcome "unknown", described as "now the discovered low blood platelets count". The patient underwent the following laboratory tests and procedures: Platelet count: low. Clinical course: The patient received the Pfizer shots and experienced a hemorrhage, subcraneal bleeding that almost killed the patient. Had surgery, and now the low blood platelet count was discovered. The reporter's assessment of the causal relationship of "experienced hemorrhage, subcraneal bleeding that almost killed me", "almost killed me" and "now the discovered low blood platelets count" with the suspect product(s) BNT162b2 omicron (lp.8.1) was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received. Amendment: This follow-up report is being submitted to amend previous information: Case narrative and suspect vaccine formulation were updated.; Sender's Comments: Based on limited information in the case provided and considering temporal association, there is reasonable possibility of causal association between the reported events Subarachnoid hemorrhage , near death experience and platelet count decreased and the suspect drug. The impact of this report on the benefit risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Test Name: Blood platelets count; Result Unstructured Data: Test Result:low